Cinctive Capital Management LP Dexcom Inc Transaction History

Cinctive Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $798,626 - $979,579	-6,992 Reduced 11.29%	54,956 $7.62 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $4.68 Million - $7.69 Million	61,948 New	61,948 $7.69 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $639,954 - $745,276	-5,690 Reduced 7.76%	67,590 $8.69 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $4.37 Million - $5.17 Million	42,064 Added 134.75%	73,280 $8.51 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $1.8 Million - $2.59 Million	-21,146 Reduced 40.38%	31,216 $3.53 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $4 Million - $4.93 Million	52,362 New	52,362 $4.22 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $116,847 - $156,782	-1,095 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $468,770 - $624,698	-5,788 Reduced 84.09%	1,095 $468,000
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $583,609 - $720,925	6,883 New	6,883 $2.47 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $199,510 - $335,297	-3,183 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $152,115 - $240,730	3,183 New	3,183 $857,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.